our investment portfolio

Many start-ups have been able to grow through our support

b.experts GmbH

Innovation: Germany’s first Company Builder in industrial biotechnology and chemistry.

Headquarters: Dortmund (BioMedizinZentrum)



Disruption/Innovation: Evolutionary development of microbial production strains for feed & food additives, pharmaceutical proteins (e.g. nanobodies) and pharmaceutical nucleic acids (e.g. mRNA) using patented sensor technology for 1,000-fold faster screening of strain libraries.

Headquarters: Research Centre Jülich

Benefits: New, tailor-made production strains are generated by evolutionary methods, which achieve higher yields (added value) in a shorter time (costs) due to patentable features (right of prohibition / unique selling proposition).



Disruption/Innovation: artificial photosynthesis to produce chemicals from CO2 (greenhouse gas), water and renewable energy using synthetic biology.

Headquarters: Dortmund (Phoenix West) and Max-Planck-Institut Potsdam Golm (Laboratories)

Benefits: a novel raw material (formate) for the biotech industry, cost benefits, new markets for renewable energy and CO2-reduction.



Disruption/Innovation: production of high-value products in plants (innovative production system) with a unprecedented quality.

Headquarters: Dortmund (Phoenix West)

Benefits: longer efficacy due to higher depot effect in applications such as osteoarthritis, dry eye, non-surgical cosmetic procedures, no irritation when injected.



Disruption/Innovation: production of a novel substance (ectoin) and its use in medical devices, cosmetics and veterinary medicine.

Dortmund (Phoenix West)

Benefits: better treatment of allergies, common cold, respiratory disease, dry eye/dry nose or inflammatory skin disease symptoms.



Disruption/Innovation: Novel production system (fermentative) for the production of natural astaxanthin.

Spin-off: Bielefeld University

Benefits: Significantly cheaper production of natural astaxanthin, which is increasingly in demand for use in food, dietary supplements, cosmetics and animal feed.



Disruption/Innovation: 3D bioprinting technology to create complex biological cell culture systems (organ models).

Headquarters: Berlin (Amperium)

Benefits: Fast and precise production of organ models, which enable researchers to discover novel drugs and to engineer functional human tissues.


Copyright 2020 b.value AG
This site uses necessary cookies to help make this website usable by providing basic features such as site navigation and access to secure areas of the site and technical protection against misuse. More information about privacy